Back

Prognostic impact of resting and exercise right ventricular to pulmonary artery coupling in patients with dynamic mitral regurgitation

30 August 2025 (08:25 - 08:35)
Organised by: Logo
Congress Presentation Part of: Mitral regurgitation and clinical consequences Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Julius Glasmacher

Medical Faculty, Heinrich Heine University, Duesseldorf (Germany)

5 More presentations in this session

Presentation thumbnail
Prevalence, clinical significance, and risk factors of arrhythmic mitral valve prolapse - results of the MITPROL AR-PL Registry.
Doctor D. Dziadosz (Katowice, PL)
Abstract Slides Video
Presentation thumbnail
Sex-specific patterns in worldwide burden of non-rheumatic degenerative mitral valve disease between 1990 and 2021, results from the Global Burden of Disease Study 2021
Doctor J. Ma (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Comorbidities and excess mortality of patients with moderate mitral regurgitation
Doctor S. Elimeleh (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
The REVEAL-AFMR score: development and validation of a prognostic model for patients with atrial functional mitral regurgitation
Doctor H. Kago (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Predictors of mitral regurgitation improvement in functional mitral regurgitation: insights from ventricular and atrial remodeling
Doctor C. Lu (Taoyuan, TW)
Abstract Slides Video

Access the full session

Session thumbnail
Mitral regurgitation and clinical consequences
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 08:25 CET
You may be interested in
thumbnail
Congress Presentation
Impact of right ventricular to pulmonary artery coupling on remodeling and outcome in patients undergoing transcatheter edge-to-edge mitral valve repair
thumbnail
Congress Presentation
Clinical application in valvular heart disease
thumbnail
Congress Session
Mitral regurgitation and clinical consequences

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources